BACKGROUND: Neuropathologic studies suggest an association between cerebral amyloid angiopathy (CAA) and small ischemic infarctions as well as hemorrhages. We examined the prevalence and associated risk factors for infarcts detected by diffusion-weighted imaging (DWI). METHODS: We performed retrospective analysis of MR images from 78 subjects with a diagnosis of probable CAA and a similar aged group of 55 subjects with Alzheimer disease or mild cognitive impairment (AD/MCI) for comparison. DWI and apparent diffusion coefficient (ADC) maps were inspected for acute or subacute infarcts. We also examined the association between DWI lesions and demographic variables, conventional vascular risk factors, and radiographic markers of CAA severity such as number of hemorrhages on gradient-echo MRI and volume of T2-hyperintense white matter lesions. RESULTS: Twelve of 78 subjects with CAA (15%) had a total of 17 DWI-hyperintense lesions consistent with subacute cerebral infarctions vs 0 of 55 subjects with AD/MCI (p = 0.001). The DWI lesions were located primarily in cortex and subcortical white matter. CAA subjects with DWI lesions had a higher median number of total hemorrhages (22 vs 4, p = 0.025) and no difference in white matter hyperintensity volume or conventional vascular risk factors compared to subjects with CAA without lesions. CONCLUSIONS: MRI evidence of small subacute infarcts is present in a substantial proportion of living patients with advanced cerebral amyloid angiopathy (CAA). The presence of these lesions is associated with a higher burden of hemorrhages, but not with conventional vascular risk factors. This suggests that advanced CAA predisposes to ischemic infarction as well as intracerebral hemorrhage.
BACKGROUND: Neuropathologic studies suggest an association between cerebral amyloid angiopathy (CAA) and small ischemic infarctions as well as hemorrhages. We examined the prevalence and associated risk factors for infarcts detected by diffusion-weighted imaging (DWI). METHODS: We performed retrospective analysis of MR images from 78 subjects with a diagnosis of probable CAA and a similar aged group of 55 subjects with Alzheimer disease or mild cognitive impairment (AD/MCI) for comparison. DWI and apparent diffusion coefficient (ADC) maps were inspected for acute or subacute infarcts. We also examined the association between DWI lesions and demographic variables, conventional vascular risk factors, and radiographic markers of CAA severity such as number of hemorrhages on gradient-echo MRI and volume of T2-hyperintense white matter lesions. RESULTS: Twelve of 78 subjects with CAA (15%) had a total of 17 DWI-hyperintense lesions consistent with subacute cerebral infarctions vs 0 of 55 subjects with AD/MCI (p = 0.001). The DWI lesions were located primarily in cortex and subcortical white matter. CAA subjects with DWI lesions had a higher median number of total hemorrhages (22 vs 4, p = 0.025) and no difference in white matter hyperintensity volume or conventional vascular risk factors compared to subjects with CAA without lesions. CONCLUSIONS: MRI evidence of small subacute infarcts is present in a substantial proportion of living patients with advanced cerebral amyloid angiopathy (CAA). The presence of these lesions is associated with a higher burden of hemorrhages, but not with conventional vascular risk factors. This suggests that advanced CAA predisposes to ischemic infarction as well as intracerebral hemorrhage.
Authors: Y W Chen; M E Gurol; J Rosand; A Viswanathan; S M Rakich; T R Groover; S M Greenberg; E E Smith Journal: Neurology Date: 2006-07-11 Impact factor: 9.910
Authors: Helen Petrovitch; G Webster Ross; Sandra C Steinhorn; Robert D Abbott; William Markesbery; Daron Davis; James Nelson; John Hardman; Kamal Masaki; Margaret R Vogt; Lenore Launer; Lon R White Journal: Ann Neurol Date: 2005-01 Impact factor: 10.422
Authors: Steven M Greenberg; Jonathan Rosand; Alexander T Schneider; L Creed Pettigrew; Samuel E Gandy; Barry Rovner; Brian-Fred Fitzsimmons; Eric E Smith; M Edip Gurol; Kristin Schwab; Julie Laurin; Denis Garceau Journal: Alzheimer Dis Assoc Disord Date: 2006 Oct-Dec Impact factor: 2.703
Authors: M E Gurol; M C Irizarry; E E Smith; S Raju; R Diaz-Arrastia; T Bottiglieri; J Rosand; J H Growdon; S M Greenberg Journal: Neurology Date: 2006-01-10 Impact factor: 9.910
Authors: R N Kaveer Nandigam; Yu-Wei Chen; Mahmut E Gurol; Jonathan Rosand; Steven M Greenberg; Eric E Smith Journal: J Neuroimaging Date: 2007-01 Impact factor: 2.486
Authors: Jason Mackey; Jeffrey J Wing; Gina Norato; Ian Sobotka; Ravi S Menon; Richard E Burgess; M Chris Gibbons; Nawar M Shara; Stephen Fernandez; Annapurni Jayam-Trouth; Laura Russell; Dorothy F Edwards; Chelsea S Kidwell Journal: Int J Stroke Date: 2015-08-26 Impact factor: 5.266
Authors: Eitan Auriel; M Brandon Westover; Matt T Bianchi; Yael Reijmer; Sergi Martinez-Ramirez; Jun Ni; Ellis Van Etten; Matthew P Frosch; Panagiotis Fotiadis; Kris Schwab; Anastasia Vashkevich; Grégoire Boulouis; Alayna P Younger; Keith A Johnson; Reisa A Sperling; Trey Hedden; M Edip Gurol; Anand Viswanathan; Steven M Greenberg Journal: Stroke Date: 2015-07-09 Impact factor: 7.914
Authors: Micaela Santos; Enikö Kövari; Patrick R Hof; Gabriel Gold; Constantin Bouras; Panteleimon Giannakopoulos Journal: Brain Res Rev Date: 2009-09-08
Authors: Ravi S Menon; Richard E Burgess; Jeffrey J Wing; M Christopher Gibbons; Nawar M Shara; Stephen Fernandez; Annapurni Jayam-Trouth; Laura German; Ian Sobotka; Dorothy Edwards; Chelsea S Kidwell Journal: Ann Neurol Date: 2012-02 Impact factor: 10.422
Authors: Laibaik Park; Joan Zhou; Ping Zhou; Rose Pistick; Sleiman El Jamal; Linda Younkin; Joseph Pierce; Andrea Arreguin; Josef Anrather; Steven G Younkin; George A Carlson; Bruce S McEwen; Costantino Iadecola Journal: Proc Natl Acad Sci U S A Date: 2013-02-04 Impact factor: 11.205
Authors: J A Molad; D T Blumenthal; F Bokstein; M Findler; I Finkel; N M Bornstein; S Yust-Katz; E Auriel Journal: J Neurooncol Date: 2016-10-18 Impact factor: 4.130